Volanesorsen and Triglyceride Levels in Familial Chylomicronemia SyndromeJoseph L. Witztum, Éric Bruckert, Daniel Gaudet et al.|New England Journal of Medicine|2019Cited by 663
Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory ResponsesNathanael J. Spann, Christopher K. Glass, Elaine W. Wang et al.|Cell|2012Cited by 598
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to <i>ANGPTL3</i> mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemiaDaniel Gaudet, Ewa Karwatowska‐Prokopczuk, Seth J. Baum et al.|European Heart Journal|2020Cited by 276
Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesionsRogier A. van Dijk, Sotirios Tsimikas|Journal of Lipid Research|2012Cited by 161
Aspirin and Cardiovascular Risk in Individuals With Elevated Lipoprotein(a): The Multi‐Ethnic Study of AtherosclerosisHarpreet Bhatia, Sotirios Tsimikas|Journal of the American Heart Association|2024Cited by 69